Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, HSTM, MDRX, RRAC, IPXX, ENPC, RENE, AXAC, and BSII

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Rigel Resource Acquisition (RRAC), Inflection Point Acquisition Corp. II (IPXX), Executive Network Partnering (ENPC), Cartesian Growth Co. II (RENE), AXIOS Sustainable Growth Acquisition (AXAC), and Black Spade Acquisition II (BSII).

Athena Technology Acquisition vs. Its Competitors

Athena Technology Acquisition (NYSE:ATEK) and Cortexyme (NASDAQ:CRTX) are both small-cap health care technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
Athena Technology AcquisitionN/A N/A N/A
Cortexyme N/A -70.96%-63.53%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Athena Technology AcquisitionN/AN/AN/AN/AN/A
CortexymeN/AN/A-$89.94M-$2.97-0.54

In the previous week, Athena Technology Acquisition and Athena Technology Acquisition both had 1 articles in the media. Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Athena Technology Acquisition
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cortexyme
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

17.3% of Athena Technology Acquisition shares are owned by institutional investors. Comparatively, 63.2% of Cortexyme shares are owned by institutional investors. 88.4% of Athena Technology Acquisition shares are owned by insiders. Comparatively, 27.9% of Cortexyme shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Athena Technology Acquisition has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Cortexyme has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500.

Summary

Athena Technology Acquisition beats Cortexyme on 4 of the 6 factors compared between the two stocks.

Get Athena Technology Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE Exchange
Market Cap$101.50M$176.31M$2.01B$20.55B
Dividend YieldN/A5.38%13.70%3.74%
P/E RatioN/A2.4812.2328.00
Price / SalesN/A412.692,542,403.6740.51
Price / CashN/A74.7861.1322.25
Price / BookN/A6.153.254.60
Net IncomeN/A$3.67M-$462.58M$982.91M

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$10.00
flat
N/AN/A$101.50MN/A0.002,021News Coverage
CRTX
Cortexyme
N/A$1.60
+5.3%
N/A+126.8%$58.79MN/A-0.5455
OMCL
Omnicell
2.7797 of 5 stars
$29.56
-0.8%
$44.83
+51.7%
+15.5%$1.40B$1.11B64.263,670Positive News
HSTM
HealthStream
4.3319 of 5 stars
$27.78
+0.1%
$31.50
+13.4%
-0.9%$846.92M$291.65M44.091,093
MDRX
Veradigm
2.9868 of 5 stars
$4.85
+3.2%
$13.00
+168.0%
-51.3%$525.09M$1.53B0.008,000Gap Up
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
IPXX
Inflection Point Acquisition Corp. II
N/A$10.52
-0.1%
N/A-7.2%$328.75MN/A0.00N/ANews Coverage
High Trading Volume
ENPC
Executive Network Partnering
N/A$6.37
-2.3%
N/A-5.4%$267.63MN/A0.001High Trading Volume
RENE
Cartesian Growth Co. II
N/A$11.75
flat
N/A+4.0%$254.05MN/A0.002
AXAC
AXIOS Sustainable Growth Acquisition
N/A$10.43
flat
N/AN/A$228.66MN/A0.00N/AHigh Trading Volume
BSII
Black Spade Acquisition II
N/A$9.99
flat
N/AN/A$191.06MN/A0.00N/A

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners